Table 1.

Characteristics of the Participants by Trial Arm

		ATSM			NASM
		n		%	N		%
Gender
	Male	53		24.20	57		26.15
	Female	166		75.80	161		73.85
Site of Cancer
	Lung	37		17.29	39		18.14
	Breast	86		40.19	88		40.93
	Colon	33		15.42	30		13.95
	Other	58		27.10	58		26.98
Stage of Cancer
	Early	66		30.84	53		24.65
	Late	148		69.16	162		75.35
Reduction in severity
	>50%	90		52.02	79		45.66
	0–49%	55		31.79	51		29.48
	Deterioration	28		16.18	43		24.86
		n	Mean	SD	n	Mean	SD
Age		218	57.12	12.00	218	57.28	11.84
Comorbidity		219	2.01	1.63	218	2.10	1.61
Symptom severity at baseline		219	36.13	22.84	218	32.53	20.90
Symptom severity at 16 weeks		173	18.33	18.74	173	19.33	18.62

SD = standard deviation.